Researchers from North Carolina State University have synthesized an analog of lipoxazolidinone A, a small molecule that is effective against drug-resistant bacteria such as MRSA. This molecule, a new synthetic compound inspired by a natural product, could be a useful chemical tool for studying other Gram-positive infections and may have implications for future drug creation.
Lipoxazolidinone A is a natural product which had been previously isolated from bacteria living in marine sediments. It is a secondary metabolite – a small molecule produced by the bacteria that isn’t key to its survival but is produced for a secondary purpose, like defense. When lipoxazolidinone A was initially isolated, researchers noted that it seemed effective against Gram-positive bacteria, like MRSA.
NC State chemist Joshua Pierce aimed to confirm those original findings and understand how the molecule’s structure correlated to its function; in short, he wanted to recreate the molecule to see what portions were directly responsible for its anti-microbial properties and then potentially improve upon that structure.
Pierce, along with current NC State graduate student Kaylib Robinson and former students Jonathan Mills and Troy Zehnder, used novel chemical tools to synthesize lipoxazolidinone A in the lab. They were able to confirm that its chemical structure matched what the initial researchers had indicated, then they worked to identify the portion of the molecule that was responsible for the activity against Gram-positive bacteria. Their result was a compound with improved potency, JJM-35.
They tested JJM-35 against a panel of resistant and non-resistant bacteria. When tested against MRSA in vitro, they found that the synthesized molecule was up to 50 times more effective than the natural product against several bacterial strains. Additionally, they found that the molecule was often more effective against resistant bacterial strains than it was against nonresistant strains.
“An exciting additional aspect of this work was that we identified that these molecules may function by inhibiting multiple biosynthetic pathways directly or indirectly,” says Pierce. “This means that bacteria may have difficulty developing resistance to potential drugs developed from these molecules.”
While more work is needed, Pierce hopes that JJM-35 and similar compounds can be used as tools to study other Gram-positive bacteria and provide a platform for the development of a novel class of anti-infective agents.
“At this point, we have a chemical scaffold – a starting piece of the puzzle. We know that this piece is effective, and so right now all efforts are focused on evaluating the properties of these molecules and their in vivo efficacy,” says Pierce. “The hope is that we can build upon this scaffold to create drugs that are effective against MRSA and other resistant bacteria at a time of dire need for antimicrobial development while also increasing the spectrum of activity.”
Learn more: New Compound Effective Against Drug-Resistant Pathogens Could Lead to Next-Generation Antibiotics
The Latest on: Antimicrobial development
[google_news title=”” keyword=”antimicrobial development” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Antimicrobial development
- Antimicrobial Resistance Market Will Reach USD 9.5 billion By 2032 And registering a CAGR of 7.6%.on May 9, 2024 at 7:00 am
The global antimicrobial resistance market was valued at $4.6 billion in 2022, and is projected to reach $9.5 billion by 2032, registering a CAGR of 7.6% from 2023 to 2032.The growth of antimicrobial ...
- 7 leaders announce support for antimicrobial use stewardship principleson May 8, 2024 at 11:58 am
USAID-funded TRANSFORM project has united 26 organizations in antimicrobial use stewardship in an effort to combat antimicrobial resistance.
- New plan to tackle antimicrobial resistance launchedon May 7, 2024 at 9:37 pm
A new plan to tackle antimicrobial resistance (AMR), a global issue that makes infections difficult or impossible to treat, has been launched today.
- Global Health Leaders Unite to Confront Urgent Public Health Crisis of Antimicrobial Resistanceon May 7, 2024 at 4:02 am
"Antimicrobial resistance is an urgent global public health threat that poses risks to modern medicine, the health of humans, animals, plants, the environment, and the global economy. Antimicrobial ...
- Purdue researcher receives $2.4 million NIH grant to combat antimicrobial resistance in lung infectionson May 6, 2024 at 2:14 pm
Qi "Tony" Zhou, a researcher in Purdue University's College of Pharmacy has received a $2.4 million grant from the National Institutes of Health to fight lung infections that have established a ...
- Industry group pushes for more progress against antimicrobial resistanceon May 6, 2024 at 12:06 pm
In the political declaration that emerged from the 2016 United Nations (UN) High-Level Meeting on Antimicrobial Resistance (AMR), UN member states called for concerted action from governments and ...
- Purdue pharmacy researcher receives $2.4M NIH grant to fight antimicrobial-resistant lung infectionson May 6, 2024 at 7:24 am
WEST LAFAYETTE, Ind. — Qi “Tony” Zhou, a researcher in Purdue University’s College of Pharmacy has received a $2.4 million grant from the National Institutes of Health to fight lung infections that ...
- Antimicrobial resistance and India’s rapidly ageing societyon May 6, 2024 at 3:01 am
The world today is grappling with an impending and existential threat of Antimicrobial Resistance (AMR) that has the potential to unsettle medical progress and the very foundations of health systems ...
- Towards transparent and antimicrobial surfaces for touch displayson May 3, 2024 at 9:07 am
Researchers report the development of a durable and transparent antimicrobial surface containing copper nanoparticles. The nanostructured surface was obtained by dewetting ultrathin metal copper films ...
via Bing News